Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 3131 of 3330
Next
>>
>
78251 to 78275 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	0.0533	uM	7483.074	0.7061	0.7976	3.2613
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	0.267	uM	7483.074	0.5405	0.6561	3.2613
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	1.33	uM	7483.074	0.4422	0.5572	3.2613
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	6.67	uM	7483.074	0.2625	0.3272	3.2613
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	33.3	uM	7483.074	0.1508	0.1197	3.2613
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	0.0000853	uM	7484.074	0.9940	0.9954	2.6137
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	0.000427	uM	7484.074	0.9858	0.9891	2.6137
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	0.00213	uM	7484.074	0.9913	0.9934	2.6137
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	0.0107	uM	7484.074	0.8107	0.8457	2.6137
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	0.0533	uM	7484.074	0.6997	0.7445	2.6137
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	0.267	uM	7484.074	0.5247	0.5627	2.6137
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	1.33	uM	7484.074	0.4336	0.4527	2.6137
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	6.67	uM	7484.074	0.2728	0.2167	2.6137
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	33.3	uM	7484.074	0.1754	0.0276	2.6137
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	0.0000853	uM	7485.074	0.9499	0.9712	3.5413
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	0.000427	uM	7485.074	0.9957	0.9976	3.5413
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	0.00213	uM	7485.074	0.8928	0.9370	3.5413
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	0.0107	uM	7485.074	0.8431	0.9059	3.5413
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	0.0533	uM	7485.074	0.6421	0.7648	3.5413
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	0.267	uM	7485.074	0.5428	0.6831	3.5413
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	1.33	uM	7485.074	0.4341	0.5801	3.5413
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	6.67	uM	7485.074	0.2386	0.3345	3.5413
MCF 10A	NM	Basal B	Triciribine	AKT	AKT	33.3	uM	7485.074	0.1270	0.1167	3.5413
MCF 10F	NM	-	Triciribine	AKT	AKT	0.0000853	uM	7487.074	0.7606	0.6493	1.4197
MCF 10F	NM	-	Triciribine	AKT	AKT	0.000427	uM	7487.074	0.9220	0.8887	1.4197

|<
<<
Previous
Page 3131 of 3330
Next
>>
>
78251 to 78275 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)